Alzheimer’s is the most common form of dementia — it causes memory loss, confusion, thinking problems and behavioral changes.

Current treatments for dermatomyositis include various immunosuppressants and immunosuppressive agents, including ...

Opens in a new tab or window An investigational monoclonal antibody targeting interferon beta (IFNβ) led to rapid and pronounced reductions in disease activity in adults with dermatomyositis ...

Altruism values for treatments of rare, severe pediatric diseases have not been estimated. This study found the altruism value for a hypothetical new Duchenne muscular dystrophy treatment to be $80 ...

In a study published in Nature Microbiology, a research team led by Prof. LIANG Xinmiao from the Dalian Institute of Chemical Physics (DICP) of the Chinese Academy of Sciences, collaborating with Prof ...

Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative ...

Researchers have improved our understanding of how rotavirus, the most common cause of acute gastroenteritis in children, makes people sick. The study is among the first to show that the rotavirus ...

Dr Cheryl Barton discusses the recent developments in neuroplastogens and how they may offer a new approach to treating neurological diseases. Neurological diseases such as treatment-resistant ...

Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company has ...

Researchers have uncovered novel insights into how brain function disruptions related to cerebrovascular disease (CeVD) ...

Eli Lilly partnership aims to identify new treatments for ALS based on antibodies from people with very slow disease ...